Stay updated on Clinical Trial: Olaparib + Abiraterone in Prostate Cancer
Sign up to get notified when there's something new on the Clinical Trial: Olaparib + Abiraterone in Prostate Cancer page.

Latest updates to the Clinical Trial: Olaparib + Abiraterone in Prostate Cancer page
- Check6 days agoNo Change Detected
- Check14 days agoChange DetectedRevision: v3.3.3 was added to the history and HHS Vulnerability Disclosure and Revision: v3.3.2 were removed; these changes are limited to metadata and do not affect study information. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check21 days agoNo Change Detected
- Check28 days agoNo Change Detected
- Check42 days agoChange DetectedA new Document Section 'Study Status' was added to the Study Record History on 2025-11-20 (Revision: v3.3.2), and a prior revision (v3.2.0) was removed on 2025-08-29. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check49 days agoChange DetectedThe old version displayed a government funding notice banner at the top of the page; the new version has removed that banner. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.6%

- Check64 days agoChange DetectedNew versions have been added to the Study Record History, with updated Study Status entries and recruitment details. These updates reflect the trial's current progression and are relevant to users tracking the study.SummaryDifference0.1%

- Check93 days agoChange DetectedSummary: The page adds a government-operating-status notice and new version v3.2.0, replacing v3.1.0.SummaryDifference11%

- Check100 days agoChange DetectedUpdated the page revision from v3.0.2 to v3.1.0, indicating a newer version is now in effect.SummaryDifference0.3%

Stay in the know with updates to Clinical Trial: Olaparib + Abiraterone in Prostate Cancer
Enter your email address, and we'll notify you when there's something new on the Clinical Trial: Olaparib + Abiraterone in Prostate Cancer page.